Vycor Medical (VYCO) Liabilities and Shareholders Equity (2010 - 2026)
Vycor Medical's (VYCO) quarterly Liabilities and Shareholders Equity came in at $854071.0 in Q1 2026, down 9.22% year-on-year from $940831.0 in Q1 2025, and up 2.85% on a QoQ basis from $830420.0 in Q4 2025.
Vycor Medical (VYCO) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $854071.0 in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 9.22% year-over-year to $854071.0 in Q1 2026; TTM through Mar 2026 was $3.5 million, a 12.61% decrease from a year earlier, with the FY2025 full-year figure at $830420.0, down 16.8% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $854071.0, up from $830420.0 in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for VYCO reached as high as $1.1 million in Q3 2024 and fell as low as $830420.0 in Q4 2025.
- Historically, Liabilities and Shareholders Equity has averaged $936733.2 across 5 years, with a median of $940831.0 in 2025.
- Across the five-year window, Liabilities and Shareholders Equity grew 16.0% in 2024 and retreated 16.8% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $860178.0 in 2022, then climbed by 15.36% to $992298.0 in 2023, then rose by 0.59% to $998117.0 in 2024, then decreased by 16.8% to $830420.0 in 2025, then climbed by 2.85% to $854071.0 in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $854071.0 in Q1 2026, $830420.0 in Q4 2025, and $941195.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 854,071.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 854,071.00 |
| Dec 31, 2025 | 830,420.00 |
| Sep 30, 2025 | 941,195.00 |
| Jun 30, 2025 | 878,946.00 |
| Mar 31, 2025 | 940,831.00 |
| Dec 31, 2024 | 998,117.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 996,972.00 |
| Mar 31, 2024 | 968,792.00 |
| Dec 31, 2023 | 992,298.00 |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 905,438.00 |
| Mar 31, 2023 | 835,156.00 |
| Dec 31, 2022 | 860,178.00 |
| Sep 30, 2022 | 949,816.00 |
| Jun 30, 2022 | 910,182.00 |
| Mar 31, 2022 | 932,979.00 |
| Dec 31, 2021 | 935,364.00 |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.06 Mn |